ACHILLES THERAPEUTICS PLC shareholder history

Current and past ACHILLES THERAPEUTICS PLC shareholders
Period Weighting Quarter
CompanyLongestShortestMin.Avg.Max.FirstLatest↓ Count
Redmile Group, LLC 11110.06%0.18%0.49%Q1 2021Q3 202311
Artal Group S.A. 11110.07%0.27%0.66%Q1 2021Q3 202311
Baker Brothers Advisors 11110.01%0.06%0.19%Q1 2021Q3 202311
BANK OF AMERICA CORP /DE/ 11110.00%0.00%0.00%Q1 2021Q3 202311
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 11110.00%0.00%0.00%Q1 2021Q3 202311
JPMORGAN CHASE & CO 820.00%0.00%0.00%Q1 2021Q3 202310
Point72 Asset Management, L.P. 990.00%0.01%0.02%Q3 2021Q3 20239
GEODE CAPITAL MANAGEMENT, LLC 990.00%0.00%0.00%Q3 2021Q3 20239
Citadel Advisors 410.00%0.00%0.00%Q1 2021Q3 20238
ROYAL BANK OF CANADA 530.00%0.00%0.00%Q2 2021Q3 20238
Syncona Portfolio Ltd 8815.03%31.66%53.06%Q4 2021Q3 20238
Renaissance Technologies 880.00%0.00%0.00%Q4 2021Q3 20238
MILLENNIUM MANAGEMENT LLC 440.00%0.00%0.00%Q1 2021Q3 20238
RA Capital Management 880.03%0.38%0.79%Q1 2021Q4 20228
AXA S.A. 880.00%0.00%0.01%Q2 2021Q1 20238
MORGAN STANLEY 430.00%0.00%0.00%Q4 2021Q3 20237
Orbimed Advisors 770.06%0.12%0.24%Q1 2021Q3 20227
Endurance Wealth Management, Inc. 770.00%0.00%0.00%Q4 2021Q2 20237
UBS Group AG 410.00%0.00%0.00%Q2 2021Q1 20236
Rockefeller Capital Management L.P. 660.00%0.00%0.00%Q2 2021Q3 20226
BlackRock Inc. 420.00%0.00%0.00%Q1 2021Q3 20226
Cubist Systematic Strategies, LLC 550.00%0.00%0.00%Q3 2021Q3 20225
Woodline Partners LP 320.01%0.03%0.09%Q1 2021Q2 20225
Forefront Analytics, LLC 550.02%0.03%0.04%Q3 2022Q3 20235
CITIGROUP INC 550.00%0.00%0.00%Q4 2021Q4 20225
GOLDMAN SACHS GROUP INC 440.00%0.00%0.00%Q4 2021Q3 20224
Tower Research Capital LLC (TRC) 440.00%0.00%0.00%Q1 2022Q4 20224
Perceptive Advisors 440.06%0.10%0.16%Q1 2021Q4 20214
SPHERA FUNDS MANAGEMENT LTD. 330.16%0.24%0.38%Q1 2021Q3 20213
Alyeska Investment Group, L.P. 330.00%0.00%0.01%Q1 2021Q3 20213
Point72 Hong Kong Ltd 330.00%0.00%0.00%Q3 2021Q1 20223
FARALLON CAPITAL MANAGEMENT LLC 330.02%0.05%0.08%Q1 2021Q3 20213
Legal & General Group Plc 210.00%0.00%0.00%Q1 2021Q1 20223
Boxer Capital, LLC 330.42%0.60%0.86%Q1 2021Q3 20213
SEI INVESTMENTS CO 210.00%0.00%0.00%Q2 2021Q3 20223
Affinity Asset Advisors, LLC 330.14%0.21%0.28%Q1 2021Q3 20213
KETTLE HILL CAPITAL MANAGEMENT, LLC 220.15%0.18%0.20%Q2 2022Q3 20222
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 220.05%0.16%0.28%Q1 2021Q2 20212
Pinz Capital Management, LP 220.03%0.04%0.05%Q1 2021Q2 20212
PEREGRINE CAPITAL MANAGEMENT LLC 220.04%0.07%0.10%Q1 2021Q2 20212
MACQUARIE GROUP LTD 220.00%0.00%0.00%Q1 2021Q2 20212
PURA VIDA INVESTMENTS, LLC 220.02%0.04%0.05%Q1 2021Q2 20212
Virtu Financial LLC 110.00%0.00%0.00%Q4 2022Q2 20232
SUSQUEHANNA INTERNATIONAL GROUP, LLP 220.00%0.00%0.00%Q4 2022Q1 20232
RAYMOND JAMES & ASSOCIATES 220.00%0.00%0.00%Q2 2023Q3 20232
Monashee Investment Management LLC 220.08%0.20%0.32%Q1 2021Q2 20212
RTW INVESTMENTS, LP 110.00%0.00%0.00%Q4 2021Q4 20211
JANE STREET GROUP, LLC 110.00%0.00%0.00%Q4 2022Q4 20221
CANTOR FITZGERALD, L. P. 110.00%0.00%0.00%Q4 2022Q4 20221
XTX Topco Ltd 110.00%0.00%0.00%Q3 2023Q3 20231
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. 110.03%0.03%0.03%Q1 2021Q1 20211
BALYASNY ASSET MANAGEMENT L.P. 110.00%0.00%0.00%Q3 2022Q3 20221
Squarepoint Ops LLC 110.00%0.00%0.00%Q1 2021Q1 20211
EDENTREE ASSET MANAGEMENT Ltd 110.03%0.03%0.03%Q2 2023Q2 20231
Coppell Advisory Solutions LLC 110.00%0.00%0.00%Q3 2023Q3 20231
LEVIN CAPITAL STRATEGIES, L.P. 110.02%0.02%0.02%Q1 2021Q1 20211
Sender Co & Partners, Inc. 110.07%0.07%0.07%Q4 2021Q4 20211
State of Wyoming 110.01%0.01%0.01%Q2 2021Q2 20211
Candriam S.C.A. 110.01%0.01%0.01%Q2 2021Q2 20211
CAAS CAPITAL MANAGEMENT LP 110.01%0.01%0.01%Q1 2021Q1 20211
China Universal Asset Management Co., Ltd. 110.00%0.00%0.00%Q3 2022Q3 20221
Qube Research & Technologies Ltd 110.00%0.00%0.00%Q3 2023Q3 20231
Jump Financial, LLC 110.00%0.00%0.00%Q4 2021Q4 20211
NORGES BANK 110.00%0.00%0.00%Q1 2021Q1 20211
ACADIAN ASSET MANAGEMENT LLC 110.00%0.00%0.00%Q3 2022Q3 20221
Ergoteles LLC 110.00%0.00%0.00%Q4 2022Q4 20221
External links

This page lists all the filers that currently own ACHILLES THERAPEUTICS PLC or have owned ACHILLES THERAPEUTICS PLC in the past.